Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-889

2 FDA label images from Mylan Institutional Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 67457-889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fosaprepitant Structural Formula (Image 02)

Fosaprepitant Structural Formula (Image 02)
A line graph showing the mean plasma concentration of aprepitant (ng/mL) over time (hours) following administration of 125 mg oral aprepitant and 115 mg intravenous fosaprepitant. The graph compares plasma levels over a 72-hour period, illustrating concentration changes for both oral and IV routes.*
FDA Label Image

Fosaprepitant For Injection 150 mg Carton Label (Image 01)

Fosaprepitant For Injection 150 mg Carton Label (Image 01)
Chemical structure diagram of fosaprepitant, showing its molecular components and bonding arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.